SCGB1A1 and pulmonary fibrosis: It was recently demonstrated that antiflammin-1, the carboxyl-terminal part of the third α-helix of SCGB1A1, has anti-inflammatory and anti-fibrotic activities in BLM-induced pulmonary fibrosis model [23].